Solving Mazes of Organelle‐Targeted Therapies with DNA Nanomachines
Advanced Materials · 2025
DOI: 10.1002/adma.202508047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, 2025. Verfasst von Muhammad Umar Farooq und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240…. Hauptthemen laut MEDLINE: DNA, Organelles, Nanostructures. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 293 Literaturangaben. Gefördert von: Natural Science Foundation of China, Sichuan Science and Technology Program, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Despite decades of research, cancer remains a growing global health challenge. Nanomaterials‐based therapeutics have shown promise, but their clinical applications are often limited by poor selectivity and undesirable side effects. Recently, deoxyribonucleic acid (DNA) based nanomachines have gained attention as intelligent drug carriers due to their ability to precisely target specific organelles. By leveraging rationally designed DNA nanomachines, it is possible to directly attack subcellular structures or deliver therapeutic agents to precise locations, triggering organelle‐mediated cell death. This innovative approach offers several advantages, including enhanced efficacy, lower dosages, minimized off‐target effects, reduced multidrug resistance, and improved therapeutic durability. This review explores the history and advancements of organelle‐targeting strategies, providing new insights into targeting the nucleus, mitochondria, endoplasmic reticulum, Golgi apparatus, and lysosomes using DNA nanomachines. The review also discusses the structures, design principles, and therapeutic mechanisms of these nanomachines, along with the integration of artificial intelligence‐driven self‐driving laboratories to enhance research growth, efficiency, and competitiveness. Finally, the current challenges, opportunities, and future directions in this evolving field are addressed, offering a roadmap for solving the intricate maze of organelle‐targeted cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
- Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, UK.
- Molecular Oncology Group, Biogipuzkoa Research Institute, San Sebastián, 20014, Spain.
- IKERBASQUE, Basque Foundation for Science, Bilbao, 48009, Spain.
- Sino-Swiss Institute of Advanced Technology, Shanghai University, Shanghai, 201800, China.
- Shanghai Jiao Tong University Sichuan Research Institute, Chengdu, Sichuan, 610213, China.
ORCID-Profile: Muhammad Umar Farooq, Charles H Lawrie, Nan-Nan Deng
Förderung
- Natural Science Foundation of China
- Sichuan Science and Technology Program
- Natural Science Foundation of Shanghai
- Interdisciplinary Program of Shanghai Jiao Tong University
- Sichuan Emei talent plan
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Farooq, M. U., Lawrie, C. H., & Deng, N. N. (2025). Solving Mazes of Organelle‐Targeted Therapies with DNA Nanomachines. Advanced Materials. https://doi.org/10.1002/adma.202508047
Vancouver
Farooq MU, Lawrie CH, Deng NN. Solving Mazes of Organelle‐Targeted Therapies with DNA Nanomachines. Advanced Materials. 2025. doi:10.1002/adma.202508047
BibTeX
@article{Farooq2025,
author = {Farooq, Muhammad Umar and Lawrie, Charles H and Deng, Nan-Nan},
title = {Solving Mazes of Organelle‐Targeted Therapies with DNA Nanomachines},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202508047}
}
EUVIMED